by In2Pharma | May 5, 2026 | News
The Netherlands A change has been made to the notification form of the Medicine Shortages and Defects Notification Centre in response to a new policy rule. The new policy rule and notification form have been implemented as of 01 April 2026. In the Netherlands,...
by In2Pharma | Feb 3, 2025 | News
Europe From January 10, 2025, manufacturers of medical devices (MDs) and in vitro diagnostic medical devices (IVDs) placed on the European Union market must report any interruptions or discontinuations in supply when it is reasonably foreseeable that such absence...
by In2Pharma | Jul 7, 2020 | News
Belgium These measures and their extension until 28th of July 2020, should lead to solutions and alternatives for all drugs needed for the treatment of COVID-19 patients in Belgium now and in the near future. On 1 April 2020, the FAMHP took steps regarding a range of...
by In2Pharma | Apr 14, 2017 | News
FMEB and IGZ On January 2nd 2017, the Medicine shortages and defects notification centre went live. The centre is coordinated by the Medicines Evaluation Board (MEB) and the Health Care Inspectorate (IGZ). Via one central point, marketing authorisation holders and...
